JENNIFER VROMAN: Open Payments
NPI 1245095314 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 35 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $502 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $260 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Indivior Inc. | 4 | $93 |
| Lundbeck LLC | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Alkermes, Inc. | 2 | $66 |
| E.R. Squibb & Sons, L.L.C. | 2 | $56 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Tris Pharma Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: VRAYLAR, REXULTI, SUBLOCADE, SPRAVATO, ARISTADA, COBENFY, ABILIFY ASIMTUFII, Auvelity.
Industry payments across NV — which companies pay providers there.
